Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Measuring Effects on intima media Thickness: an Evaluation Of Rosuvastatin in subclinical atherosclerosis--the rationale and methodology of the METEOR study.
Crouse JR 3rd, Grobbee DE, O'Leary DH, Bots ML, Evans GW, Palmer MK, Riley WA, Raichlen JS; Measuring Effects on intima media Thickness: an Evalution Of Rosuvastatin study group. Crouse JR 3rd, et al. Among authors: raichlen js. Cardiovasc Drugs Ther. 2004 May;18(3):231-8. doi: 10.1023/B:CARD.0000033645.55138.3d. Cardiovasc Drugs Ther. 2004. PMID: 15229392 Clinical Trial.
Does baseline carotid intima-media thickness modify the effect of rosuvastatin when compared with placebo on carotid intima-media thickness progression? The METEOR study.
Crouse JR 3rd, Bots ML, Evans GW, Palmer MK, O'Leary DH, Grobbee DE, Raichlen JS; METEOR Study Group. Crouse JR 3rd, et al. Among authors: raichlen js. Eur J Cardiovasc Prev Rehabil. 2010 Apr;17(2):223-9. doi: 10.1097/HJR.0b013e3283359c38. Eur J Cardiovasc Prev Rehabil. 2010. PMID: 20038840 Clinical Trial.
Effect of rosuvastatin on the echolucency of the common carotid intima-media in low-risk individuals: the METEOR trial.
Lind L, Peters SA, den Ruijter HM, Palmer MK, Grobbee DE, Crouse JR 3rd, O'Leary DH, Evans GW, Raichlen JS, Bots ML; METEOR Study Group. Lind L, et al. Among authors: raichlen js. J Am Soc Echocardiogr. 2012 Oct;25(10):1120-1127.e1. doi: 10.1016/j.echo.2012.07.004. Epub 2012 Aug 9. J Am Soc Echocardiogr. 2012. PMID: 22884641 Clinical Trial.
C-reactive protein lowering with rosuvastatin in the METEOR study.
Peters SA, Palmer MK, Grobbee DE, Crouse JR 3rd, O'Leary DH, Raichlen JS, Bots ML. Peters SA, et al. Among authors: raichlen js. J Intern Med. 2010 Aug;268(2):155-61. doi: 10.1111/j.1365-2796.2010.02230.x. Epub 2010 Mar 6. J Intern Med. 2010. PMID: 20412373 Free article. Clinical Trial.
73 results